Verdant Nature, LLC (Wyoming), manufacturer of the Verdant Oasis brand, has announced its partnership with CReDO

Science (Austin, TX) headed by world renowned medical cannabinoid expert Ethan Russo, MD. CReDO Science has aligned with Verdant Nature to consult on the development of proprietary, high-quality hemp-derived formulations for companies positioning their products in the CBD category.

Russo, is a board-certified neurologist and one of the most prolific and revered psychopharmacology researchers and formulators in the field of medical cannabis, according to the company. He has written more than 50 peer-reviewed journal articles and seven books on cannabis and the endocannabinoid system and served as the medical monitor and study physician for 23 clinical trials for cannabis-based pharmaceuticals.

“Having Dr. Russo work with Verdant Nature R&D catapults our ability to support our clients in crafting distinctive endocannabinoid system support products.” stated Carl Germano, CNS, CDN, vice president of Verdant Nature. “Dr. Russo’s impeccable credentials and expertise in cannabinoid medicine will provide the guidance needed to help our clients stand out among the single magic bullet CBD products pervading the marketplace.”

“Verdant Nature shares our philosophy that consumers deserve to have confidence when purchasing CBD products that the formulations will be based on the best available science, organically grown, standardized, shelf-stable and produced with good manufacturing practices (GMP),” stated Russo.

“In a setting today where the market is flooded with CBD and other products of dubious origin and composition, Verdant stands out as a beacon of quality and leads the global hemp industry by producing versatile best in class hemp oil products which meet the highest standards and practices in every aspect of hemp production,” added Russo.

For more information, visit  www.verdantoasis.com or www.credo-science.com.